©Author(s) (or their employer(s)) 2026.
World J Gastroenterol. Mar 14, 2026; 32(10): 114946
Published online Mar 14, 2026. doi: 10.3748/wjg.v32.i10.114946
Published online Mar 14, 2026. doi: 10.3748/wjg.v32.i10.114946
Figure 1
PRISMA flow diagram on selection of studies.
Figure 2 Mechanism of liver injury secondary to cystic fibrosis transmembrane conductance regulator modulator exposure.
CFTR: Cystic fibrosis transmembrane conductance regulator; DILI: Drug induced liver injury; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; LFT: Liver function test.
- Citation: Lee J, Yekula A, Wexler A, Zhuang W, Elangovan A, Rosario J, Burger P, Ramaraju G, Addissie B, Lim N, Narkewicz MR, Twohig P. Decoding liver injury in cystic fibrosis: How to tell drug-induced liver injury from cystic fibrosis liver disease. World J Gastroenterol 2026; 32(10): 114946
- URL: https://www.wjgnet.com/1007-9327/full/v32/i10/114946.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i10.114946
